FPA150 in Patients With Advanced Solid Tumors
Clinical trial NCT03514121 · TERMINATED
Trial details
- NCT number
- NCT03514121
- Sponsor
- Five Prime Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-27
- Primary completion
- 2021-04-21
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.